{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:02:48Z","timestamp":1767027768817,"version":"3.48.0"},"reference-count":58,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glaucoma, a leading cause of irreversible blindness worldwide, is a progressive optic neuropathy characterized by the apoptotic loss of retinal ganglion cells (RGCs) and elevated intraocular pressure. Current intraocular pressure-lowering therapies often fail to halt disease progression, creating an urgent need for neuroprotective and regenerative strategies. Stem cell therapy, leveraging the dual capabilities of differentiation and paracrine signaling, has emerged as a transformative approach for glaucomatous optic neuropathy. This review critically appraises recent advancements in stem cell-based interventions, focusing on three core therapeutic strategies: RGC regeneration, paracrine-mediated neuroprotection, and restoration of trabecular meshwork function for intraocular pressure regulation. We systematically synthesized evidence from preclinical and clinical studies, highlighting the efficacy of embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and adult stem cells in promoting retinal repair and neuroprotection. Despite promising results, significant translational challenges persist, including poor graft integration, tumorigenic risks, immune rejection, and the limitations of current animal models. We further discuss emerging technologies such as CRISPR\/Cas9 gene editing and 3D bioprinting, which offer potential solutions for personalized and combinatory therapies. This review underscores that while stem cell therapy holds immense potential, overcoming these scientific and technical barriers is essential for its clinical translation into effective treatments for glaucoma.<\/jats:p>","DOI":"10.1515\/biol-2025-1205","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:58:26Z","timestamp":1767027506000},"source":"Crossref","is-referenced-by-count":0,"title":["Stem cell-based approaches for glaucoma treatment: a mini review"],"prefix":"10.1515","volume":"20","author":[{"given":"Xirui","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology , First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology , First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine , First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6697-3177","authenticated-orcid":false,"given":"Shuwen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology , First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Peripheral Vascular Medicine , First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Medicine , Heilongjiang Academy of Traditional Chinese Medicine , Harbin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025122916582218140_j_biol-2025-1205_ref_001","doi-asserted-by":"crossref","unstructured":"Jayaram, H, Kolko, M, Friedman, DS, Gazzard, G. Glaucoma: now and beyond. Lancet 2023;402:1788\u2013801. https:\/\/doi.org\/10.1016\/s0140-6736(23)01289-8.","DOI":"10.1016\/S0140-6736(23)01289-8"},{"key":"2025122916582218140_j_biol-2025-1205_ref_002","doi-asserted-by":"crossref","unstructured":"Yang, X, Li, S, Guo, H, Wang, S, Sun, H, Wang, J, et al.. Metabolic dysregulation in glaucoma. Clin Exp Optom 2025;108:771\u20137. https:\/\/doi.org\/10.1080\/08164622.2025.2463502.","DOI":"10.1080\/08164622.2025.2463502"},{"key":"2025122916582218140_j_biol-2025-1205_ref_003","doi-asserted-by":"crossref","unstructured":"Yang, X, Li, S, Guo, H, Wang, S, Sun, H, Wang, J, et al.. Emerging roles of the immune microenvironment in glaucoma. Clin Exp Optom 2025:1\u20137. https:\/\/doi.org\/10.1080\/08164622.2025.2525299.","DOI":"10.1080\/08164622.2025.2525299"},{"key":"2025122916582218140_j_biol-2025-1205_ref_004","doi-asserted-by":"crossref","unstructured":"Wang, X, Sun, L, Han, X, Li, Z, Xing, Y, Chen, X, et al.. The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (Review). Int J Mol Med 2025;55:63. https:\/\/doi.org\/10.3892\/ijmm.2025.5504.","DOI":"10.3892\/ijmm.2025.5504"},{"key":"2025122916582218140_j_biol-2025-1205_ref_005","doi-asserted-by":"crossref","unstructured":"Papadopoulos, M, Vanner, EA, Grajewski, AL, Mithra, A, Pillai, M, Upadhyaya, S, et al.. International study of childhood glaucoma\u00a0\u2013\u00a0childhood glaucoma research network study G. international study of childhood glaucoma. Ophthalmol Glaucoma 2020;3:145\u201357. https:\/\/doi.org\/10.1016\/j.ogla.2019.12.007.","DOI":"10.1016\/j.ogla.2019.12.007"},{"key":"2025122916582218140_j_biol-2025-1205_ref_006","doi-asserted-by":"crossref","unstructured":"Weinreb, RN, Aung, T, Medeiros, FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311:1901\u201311. https:\/\/doi.org\/10.1001\/jama.2014.3192.","DOI":"10.1001\/jama.2014.3192"},{"key":"2025122916582218140_j_biol-2025-1205_ref_007","doi-asserted-by":"crossref","unstructured":"Kang, JM, Tanna, AP. Glaucoma. Med Clin North Am 2021;105:493\u2013510. https:\/\/doi.org\/10.1016\/j.mcna.2021.01.004.","DOI":"10.1016\/j.mcna.2021.01.004"},{"key":"2025122916582218140_j_biol-2025-1205_ref_008","doi-asserted-by":"crossref","unstructured":"Kolios, G, Moodley, Y. Introduction to stem cells and regenerative medicine. Respiration 2013;85:3\u201310. https:\/\/doi.org\/10.1159\/000345615.","DOI":"10.1159\/000345615"},{"key":"2025122916582218140_j_biol-2025-1205_ref_009","doi-asserted-by":"crossref","unstructured":"Guo, W, Wang, H, Chen, P, Shen, X, Zhang, B, Liu, J, et al.. Identification and characterization of multiple myeloma stem cell-like cells. Cancers (Basel) 2021;13:3523. https:\/\/doi.org\/10.3390\/cancers13143523.","DOI":"10.3390\/cancers13143523"},{"key":"2025122916582218140_j_biol-2025-1205_ref_010","doi-asserted-by":"crossref","unstructured":"Urban, N, Blomfield, IM, Guillemot, F. Quiescence of adult Mammalian\u00a0neural stem cells: a highly regulated rest. Neuron 2019;104:834\u201348. https:\/\/doi.org\/10.1016\/j.neuron.2019.09.026.","DOI":"10.1016\/j.neuron.2019.09.026"},{"key":"2025122916582218140_j_biol-2025-1205_ref_011","doi-asserted-by":"crossref","unstructured":"Temple, S. Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell 2023;30:512\u201329. https:\/\/doi.org\/10.1016\/j.stem.2023.03.017.","DOI":"10.1016\/j.stem.2023.03.017"},{"key":"2025122916582218140_j_biol-2025-1205_ref_012","doi-asserted-by":"crossref","unstructured":"Ajekiigbe, VO, Agbo, CE, Ogieuhi, IJ, Anthony, CS, Adewole, OA, Ahmed, B, et al.. Innovative approaches to treatment of eye diseases: advances in stem cell therapy use in ophthalmology. Int Ophthalmol 2025;45:113. https:\/\/doi.org\/10.1007\/s10792-025-03493-7.","DOI":"10.1007\/s10792-025-03493-7"},{"key":"2025122916582218140_j_biol-2025-1205_ref_013","doi-asserted-by":"crossref","unstructured":"Daliri, K, Ljubimov, AV, Hekmatimoghaddam, S. Glaucoma, stem cells, and gene therapy: where are we now? Int J Stem Cells 2017;10:119\u201328. https:\/\/doi.org\/10.15283\/ijsc17029.","DOI":"10.15283\/ijsc17029"},{"key":"2025122916582218140_j_biol-2025-1205_ref_014","doi-asserted-by":"crossref","unstructured":"Sluch, VM, Zack, DJ. Stem cells, retinal ganglion cells and glaucoma. Dev Ophthalmol 2014;53:111\u201321. https:\/\/doi.org\/10.1159\/000358409.","DOI":"10.1159\/000358409"},{"key":"2025122916582218140_j_biol-2025-1205_ref_015","doi-asserted-by":"crossref","unstructured":"Soucy, JR, Aguzzi, EA, Cho, J, Gilhooley, MJ, Keuthan, C, Luo, Z, et al.. Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe consortium. Mol Neurodegener 2023;18:64. https:\/\/doi.org\/10.1186\/s13024-023-00655-y.","DOI":"10.1186\/s13024-023-00655-y"},{"key":"2025122916582218140_j_biol-2025-1205_ref_016","doi-asserted-by":"crossref","unstructured":"Guo, X, Zhou, J, Starr, C, Mohns, EJ, Li, Y, Chen, EP, et al.. Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell 2021;184:4299\u2013314+e4212. https:\/\/doi.org\/10.1016\/j.cell.2021.06.031.","DOI":"10.1016\/j.cell.2021.06.031"},{"key":"2025122916582218140_j_biol-2025-1205_ref_017","doi-asserted-by":"crossref","unstructured":"Gomes, C, VanderWall, KB, Pan, Y, Lu, X, Lavekar, SS, Huang, KC, et al.. Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells. Stem Cell Rep 2022;17:1636\u201349. https:\/\/doi.org\/10.1016\/j.stemcr.2022.05.006.","DOI":"10.1016\/j.stemcr.2022.05.006"},{"key":"2025122916582218140_j_biol-2025-1205_ref_018","doi-asserted-by":"crossref","unstructured":"Yu, B, Wang, K, Hao, H, Liu, Y, Yue, Y, Li, X, et al.. Small extracellular vesicles derived from microRNA-22-3p-overexpressing mesenchymal stem cells protect retinal ganglion cells by regulating MAPK pathway. Commun Biol 2024;7:807. https:\/\/doi.org\/10.1038\/s42003-024-06511-z.","DOI":"10.1038\/s42003-024-06511-z"},{"key":"2025122916582218140_j_biol-2025-1205_ref_019","doi-asserted-by":"crossref","unstructured":"Li, G, Luo, Y. Enriching new transplantable RGC-Like cells from retinal organoids for RGC replacement therapy. Biochem Biophys Res Commun 2024;700:149509. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149509.","DOI":"10.1016\/j.bbrc.2024.149509"},{"key":"2025122916582218140_j_biol-2025-1205_ref_020","doi-asserted-by":"crossref","unstructured":"Hu, BY, Xin, M, Chen, M, Yu, P, Zeng, LZ. Mesenchymal stem cells for repairing glaucomatous optic nerve. Int J Ophthalmol 2024;17:748\u201360. https:\/\/doi.org\/10.18240\/ijo.2024.04.20.","DOI":"10.18240\/ijo.2024.04.20"},{"key":"2025122916582218140_j_biol-2025-1205_ref_021","doi-asserted-by":"crossref","unstructured":"Li, D, Gong, Y. A promising strategy for non-arteritic anterior ischemic optic neuropathy: intravitreal mesenchymal stem cell exosome. Curr Stem Cell Res Ther 2021;16:109\u201314. https:\/\/doi.org\/10.2174\/1574888x15666200814121849.","DOI":"10.2174\/1574888X15666200814121849"},{"key":"2025122916582218140_j_biol-2025-1205_ref_022","doi-asserted-by":"crossref","unstructured":"Bull, ND, Irvine, KA, Franklin, RJ, Martin, KR. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Investig Ophthalmol Vis Sci 2009;50:4244\u201353. https:\/\/doi.org\/10.1167\/iovs.08-3239.","DOI":"10.1167\/iovs.08-3239"},{"key":"2025122916582218140_j_biol-2025-1205_ref_023","doi-asserted-by":"crossref","unstructured":"Xia, Q, Chen, W, Xiong, J, Mo, X. MicroRNA-21-5p from induced pluripotent stem cells promotes neuroprotection of retinal ganglion cells in optic nerve crush model. BMC Ophthalmol 2025;25:442. https:\/\/doi.org\/10.1186\/s12886-025-04244-z.","DOI":"10.1186\/s12886-025-04244-z"},{"key":"2025122916582218140_j_biol-2025-1205_ref_024","doi-asserted-by":"crossref","unstructured":"Ji, S, Peng, Y, Liu, J, Xu, P, Tang, S. Human adipose tissue-derived stem cell extracellular vesicles attenuate ocular hypertension-induced retinal ganglion cell damage by inhibiting microglia- TLR4\/MAPK\/NF-kappaB proinflammatory Cascade signaling. Acta Neuropathol Commun 2024;12:44. https:\/\/doi.org\/10.1186\/s40478-024-01753-8.","DOI":"10.1186\/s40478-024-01753-8"},{"key":"2025122916582218140_j_biol-2025-1205_ref_025","doi-asserted-by":"crossref","unstructured":"Yu, F, Wang, Y, Huang, CQ, Lin, SJ, Gao, RX, Wu, RY. Neuroprotective effect of mesenchymal stem cell-derived extracellular vesicles on optic nerve injury in chronic ocular hypertension. Neural Regen Res 2023;18:2301\u20136. https:\/\/doi.org\/10.4103\/1673-5374.369121.","DOI":"10.4103\/1673-5374.369121"},{"key":"2025122916582218140_j_biol-2025-1205_ref_026","doi-asserted-by":"crossref","unstructured":"Mead, B, Hill, LJ, Blanch, RJ, Ward, K, Logan, A, Berry, M, et al.. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Cytotherapy 2016;18:487\u201396. https:\/\/doi.org\/10.1016\/j.jcyt.2015.12.002.","DOI":"10.1016\/j.jcyt.2015.12.002"},{"key":"2025122916582218140_j_biol-2025-1205_ref_027","doi-asserted-by":"crossref","unstructured":"Zeppieri, M, Musa, M. Beyond the dusty fog: local eye drop therapy and potentially new treatment alternatives in pseudoexfoliative glaucoma. Curr Med Chem 2024;31:1608\u201319. https:\/\/doi.org\/10.2174\/0109298673255220231010073215.","DOI":"10.2174\/0109298673255220231010073215"},{"key":"2025122916582218140_j_biol-2025-1205_ref_028","doi-asserted-by":"crossref","unstructured":"Kumar, A, Yang, E, Du, Y. Trabecular meshwork regeneration for glaucoma treatment using stem cell-derived trophic factors. Methods Mol Biol 2025;2848:59\u201371. https:\/\/doi.org\/10.1007\/978-1-0716-4087-6_4.","DOI":"10.1007\/978-1-0716-4087-6_4"},{"key":"2025122916582218140_j_biol-2025-1205_ref_029","doi-asserted-by":"crossref","unstructured":"Savoj, S, Esfahani, MHN, Karimi, A, Karamali, F. Integrated stem cells from apical papilla in a 3D culture system improve human embryonic stem cell derived retinal organoid formation. Life Sci 2022;291:120273. https:\/\/doi.org\/10.1016\/j.lfs.2021.120273.","DOI":"10.1016\/j.lfs.2021.120273"},{"key":"2025122916582218140_j_biol-2025-1205_ref_030","doi-asserted-by":"crossref","unstructured":"Dhamodaran, K, Subramani, M, Ponnalagu, M, Shetty, R, Das, D. Ocular stem cells: a status update. Stem Cell Res Ther 2014;5:56. https:\/\/doi.org\/10.1186\/scrt445.","DOI":"10.1186\/scrt445"},{"key":"2025122916582218140_j_biol-2025-1205_ref_031","doi-asserted-by":"crossref","unstructured":"Zhu, W, Godwin, CR, Cheng, L, Scheetz, TE, Kuehn, MH. Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes. Sci Rep 2020;10:2905. https:\/\/doi.org\/10.1038\/s41598-020-59941-0.","DOI":"10.1038\/s41598-020-59941-0"},{"key":"2025122916582218140_j_biol-2025-1205_ref_032","doi-asserted-by":"crossref","unstructured":"Sihota, R, Sen, S, Mohanty, S, Ahmad, M, Ravi, A, Gupta, V, et al.. Effect of intracameral human cord blood-derived stem cells on lasered rabbit trabecular meshwork. Int Ophthalmol 2019;39:2757\u201366. https:\/\/doi.org\/10.1007\/s10792-019-01120-w.","DOI":"10.1007\/s10792-019-01120-w"},{"key":"2025122916582218140_j_biol-2025-1205_ref_033","doi-asserted-by":"crossref","unstructured":"Hua, ZQ, Liu, H, Wang, N, Jin, ZB. Towards stem cell-based neuronal regeneration for glaucoma. Prog Brain Res 2020;257:99\u2013118. https:\/\/doi.org\/10.1016\/bs.pbr.2020.05.026.","DOI":"10.1016\/bs.pbr.2020.05.026"},{"key":"2025122916582218140_j_biol-2025-1205_ref_034","doi-asserted-by":"crossref","unstructured":"Gill, KP, Hewitt, AW, Davidson, KC, Pebay, A, Wong, RC. Methods of retinal ganglion cell differentiation from pluripotent stem cells. Transl Vis Sci Technol 2014;3:7. https:\/\/doi.org\/10.1167\/tvst.3.3.7.","DOI":"10.1167\/tvst.3.3.7"},{"key":"2025122916582218140_j_biol-2025-1205_ref_035","doi-asserted-by":"crossref","unstructured":"Stern, JH, Tian, Y, Funderburgh, J, Pellegrini, G, Zhang, K, Goldberg, JL, et al.. Regenerating eye tissues to preserve and restore vision. Cell Stem Cell 2018;22:834\u201349. https:\/\/doi.org\/10.1016\/j.stem.2018.05.013.","DOI":"10.1016\/j.stem.2018.05.013"},{"key":"2025122916582218140_j_biol-2025-1205_ref_036","unstructured":"Deng, F, Chen, M, Liu, Y, Hu, H, Xiong, Y, Xu, C, et al.. Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage. Mol Vis 2016;22:536\u201347."},{"key":"2025122916582218140_j_biol-2025-1205_ref_037","doi-asserted-by":"crossref","unstructured":"Bull, ND, Limb, GA, Martin, KR. Human muller stem cell (MIO-M1) transplantation in a rat model of glaucoma: survival, differentiation, and integration. Investig Ophthalmol Vis Sci 2008;49:3449\u201356. https:\/\/doi.org\/10.1167\/iovs.08-1770.","DOI":"10.1167\/iovs.08-1770"},{"key":"2025122916582218140_j_biol-2025-1205_ref_038","doi-asserted-by":"crossref","unstructured":"Croteau, LP, Risner, ML, Wareham, LK, McGrady, NR, Chamling, X, Zack, DJ, et al.. Ex vivo integration of human stem retinal ganglion cells into the mouse retina. Cells 2022;11:3241. https:\/\/doi.org\/10.3390\/cells11203241.","DOI":"10.3390\/cells11203241"},{"key":"2025122916582218140_j_biol-2025-1205_ref_039","doi-asserted-by":"crossref","unstructured":"Zhang, KY, Aguzzi, EA, Johnson, TV. Retinal ganglion cell transplantation: approaches for overcoming challenges to functional integration. Cells 2021;10:1426. https:\/\/doi.org\/10.3390\/cells10061426.","DOI":"10.3390\/cells10061426"},{"key":"2025122916582218140_j_biol-2025-1205_ref_040","doi-asserted-by":"crossref","unstructured":"Edo, A, Sugita, S, Futatsugi, Y, Sho, J, Onishi, A, Kiuchi, Y, et al.. Capacity of retinal ganglion cells derived from human induced pluripotent stem cells to suppress T-cells. Int J Mol Sci 2020;21:7831. https:\/\/doi.org\/10.3390\/ijms21217831.","DOI":"10.3390\/ijms21217831"},{"key":"2025122916582218140_j_biol-2025-1205_ref_041","doi-asserted-by":"crossref","unstructured":"Vilela, CAP, Messias, A, Calado, RT, Siqueira, RC, Silva, MJL, Covas, DT, et al.. Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma. Doc Ophthalmol 2021;143:33\u20138. https:\/\/doi.org\/10.1007\/s10633-021-09817-z.","DOI":"10.1007\/s10633-021-09817-z"},{"key":"2025122916582218140_j_biol-2025-1205_ref_042","doi-asserted-by":"crossref","unstructured":"Lo, B, Parham, L. Ethical issues in stem cell research. Endocr Rev 2009;30:204\u201313. https:\/\/doi.org\/10.1210\/er.2008-0031.","DOI":"10.1210\/er.2008-0031"},{"key":"2025122916582218140_j_biol-2025-1205_ref_043","doi-asserted-by":"crossref","unstructured":"Wong, NK, Yip, SP, Huang, CL. Establishing functional retina in a dish: progress and promises of induced pluripotent stem cell-based retinal neuron differentiation. Int J Mol Sci 2023;24:13652. https:\/\/doi.org\/10.3390\/ijms241713652.","DOI":"10.3390\/ijms241713652"},{"key":"2025122916582218140_j_biol-2025-1205_ref_044","doi-asserted-by":"crossref","unstructured":"Kahraman, NS, Oner, A. Umbilical cord-derived mesenchymal stem cell implantation in patients with optic atrophy. Eur J Ophthalmol 2021;31:3463\u201370. https:\/\/doi.org\/10.1177\/1120672120977824.","DOI":"10.1177\/1120672120977824"},{"key":"2025122916582218140_j_biol-2025-1205_ref_045","doi-asserted-by":"crossref","unstructured":"Denny, MR, Chu, FB, Cheung, AY, Holland, EJ. Comparison of glaucoma drainage device versus transscleral cyclophotocoagulation for secondary glaucoma following ocular surface stem cell transplantation. J\u00a0Glaucoma 2021;30:e119\u201322. https:\/\/doi.org\/10.1097\/ijg.0000000000001723.","DOI":"10.1097\/IJG.0000000000001723"},{"key":"2025122916582218140_j_biol-2025-1205_ref_046","unstructured":"Capozzi, P, Petroni, S, Buzzonetti, L. Combined HLA matched limbal stem cells allograft with amniotic membrane transplantation as a prophylactic surgical procedure to prevent corneal graft rejection after penetrating keratoplasty: case report. Ann Ist Super Sanita 2014;50:298\u2013300. https:\/\/doi.org\/10.4415\/ANN_14_03_13."},{"key":"2025122916582218140_j_biol-2025-1205_ref_047","doi-asserted-by":"crossref","unstructured":"Johnson, TV, Bull, ND, Hunt, DP, Marina, N, Tomarev, SI, Martin, KR. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Investig Ophthalmol Vis Sci 2010;51:2051\u20139. https:\/\/doi.org\/10.1167\/iovs.09-4509.","DOI":"10.1167\/iovs.09-4509"},{"key":"2025122916582218140_j_biol-2025-1205_ref_048","doi-asserted-by":"crossref","unstructured":"Soucy, JR, Todd, L, Kriukov, E, Phay, M, Malechka, VV, Rivera, JD, et al.. Controlling donor and newborn neuron migration and maturation in the eye through microenvironment engineering. Proc Natl Acad Sci U S A 2023;120:e2302089120. https:\/\/doi.org\/10.1073\/pnas.2302089120.","DOI":"10.1073\/pnas.2302089120"},{"key":"2025122916582218140_j_biol-2025-1205_ref_049","doi-asserted-by":"crossref","unstructured":"Luis, J, Eastlake, K, Lamb, WDB, Limb, GA, Jayaram, H, Khaw, PT. Cell-based therapies for glaucoma. Transl Vis Sci Technol 2023;12:23. https:\/\/doi.org\/10.1167\/tvst.12.7.23.","DOI":"10.1167\/tvst.12.7.23"},{"key":"2025122916582218140_j_biol-2025-1205_ref_050","doi-asserted-by":"crossref","unstructured":"Jain, A, Zode, G, Kasetti, RB, Ran, FA, Yan, W, Sharma, TP, et al.. CRISPR-Cas9-based treatment of myocilin-associated glaucoma. Proc Natl Acad Sci USA 2017;114:11199\u2013204. https:\/\/doi.org\/10.1073\/pnas.1706193114.","DOI":"10.1073\/pnas.1706193114"},{"key":"2025122916582218140_j_biol-2025-1205_ref_051","doi-asserted-by":"crossref","unstructured":"Jiang, J, Kong, K, Fang, X, Wang, D, Zhang, Y, Wang, P, et al.. CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma. Cell Rep Med 2024;5:101524. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101524.","DOI":"10.1016\/j.xcrm.2024.101524"},{"key":"2025122916582218140_j_biol-2025-1205_ref_052","doi-asserted-by":"crossref","unstructured":"Wu, KY, Tabari, A, Mazerolle, E, Tran, SD. Towards precision ophthalmology: the role of 3D printing and bioprinting in oculoplastic surgery, retinal, corneal, and glaucoma treatment. Biomimetics (Basel) 2024;9:145. https:\/\/doi.org\/10.3390\/biomimetics9030145.","DOI":"10.3390\/biomimetics9030145"},{"key":"2025122916582218140_j_biol-2025-1205_ref_053","doi-asserted-by":"crossref","unstructured":"Tan, G, Ioannou, N, Mathew, E, Tagalakis, AD, Lamprou, DA, Yu-Wai-Man, C. 3D printing in ophthalmology: from medical implants to personalised medicine. Int J Pharm 2022;625:122094. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122094.","DOI":"10.1016\/j.ijpharm.2022.122094"},{"key":"2025122916582218140_j_biol-2025-1205_ref_054","doi-asserted-by":"crossref","unstructured":"Alonzo, M, AnilKumar, S, Roman, B, Tasnim, N, Joddar, B. 3D bioprinting of cardiac tissue and cardiac stem cell therapy. Transl Res 2019;211:64\u201383. https:\/\/doi.org\/10.1016\/j.trsl.2019.04.004.","DOI":"10.1016\/j.trsl.2019.04.004"},{"key":"2025122916582218140_j_biol-2025-1205_ref_055","doi-asserted-by":"crossref","unstructured":"Woodward, DF, Chen, J. Fixed-combination and emerging glaucoma therapies. Expert Opin Emerg Drugs 2007;12:313\u201327. https:\/\/doi.org\/10.1517\/14728214.12.2.313.","DOI":"10.1517\/14728214.12.2.313"},{"key":"2025122916582218140_j_biol-2025-1205_ref_056","doi-asserted-by":"crossref","unstructured":"Tay, CY, Sathiyanathan, P, Chu, SW, Stanton, LW, Wong, TT. Identification and characterization of mesenchymal stem cells derived from the trabecular meshwork of the human eye. Stem Cell Dev. 2012;21:1381\u201390. https:\/\/doi.org\/10.1089\/scd.2011.0655.","DOI":"10.1089\/scd.2011.0655"},{"key":"2025122916582218140_j_biol-2025-1205_ref_057","doi-asserted-by":"crossref","unstructured":"Moroi, SE, Reed, DM, Sanders, DS, Almazroa, A, Kagemann, L, Shah, N, et al.. Precision medicine to prevent glaucoma-related blindness. Curr Opin Ophthalmol 2019;30:187\u201398. https:\/\/doi.org\/10.1097\/icu.0000000000000564.","DOI":"10.1097\/ICU.0000000000000564"},{"key":"2025122916582218140_j_biol-2025-1205_ref_058","doi-asserted-by":"crossref","unstructured":"Chan, L, Moster, MR, Bicket, AK, Sheybani, A, Sarkisian, SR, Samuelson, TW, et al.. New devices in glaucoma. Ophthalmol Ther 2023;12:2381\u201395. https:\/\/doi.org\/10.1007\/s40123-023-00780-3.","DOI":"10.1007\/s40123-023-00780-3"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1205\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:58:33Z","timestamp":1767027513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1205\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,1,27]]}},"alternative-id":["10.1515\/biol-2025-1205"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1205","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251205"}}